Fujirebio

Fujirebio is a multinational in-vitro diagnostics (IVD) company specializing in high-quality testing solutions. With a strong focus on neurodegenerative diseases, particularly Alzheimer's disease, Fujirebio develops and manufactures diagnostic tests and platforms used in clinical laboratories and research settings worldwide.

The company's history dates back to the establishment of its predecessor company in Japan. Over the years, Fujirebio has expanded its product portfolio and global presence through strategic acquisitions and organic growth. Key areas of focus include:

• Neurodiagnostics: Developing assays for the early detection and diagnosis of Alzheimer's disease and other neurological disorders, including biomarkers related to amyloid plaques and tau tangles.
• Specialty Diagnostics: Providing a range of diagnostic tests for infectious diseases, autoimmune disorders, and other clinical conditions.
• OEM/Contract Manufacturing: Partnering with other diagnostic companies to develop and manufacture IVD products.

Fujirebio's commitment to innovation and quality has established it as a significant player in the IVD industry. Its products are used by clinicians and researchers to improve patient care and advance scientific understanding of disease. The company emphasizes collaborations with leading researchers and healthcare professionals to develop cutting-edge diagnostic solutions.